You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Brazil Patent: PI0512177


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0512177

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,039,009 Sep 24, 2029 Abbvie NAMENDA XR memantine hydrochloride
8,039,009 Sep 24, 2029 Abbvie NAMZARIC donepezil hydrochloride; memantine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BRPI0512177: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the Scope of Patent BRPI0512177?

Patent BRPI0512177 covers a specific pharmaceutical formulation or process, as detailed in the claims section. The scope hinges on the exact claims, which define the legal protections and boundaries. The patent appears to focus on:

  • A novel drug compound or a specific combination thereof.
  • A formulation designed for improved stability, bioavailability, or targeted delivery.
  • A manufacturing method intended to enhance yield or purity.

The patent's geographical scope is limited to Brazil, but it may be part of a broader international patent strategy if counterparts exist in other jurisdictions.

What Are the Claims and Their Implications?

The claims determine the scope of exclusivity. They are generally divided into independent and dependent claims. Based on the available documentation, the key claims include:

  • An independent claim covering a specific compound or composition, possibly with a specified chemical structure.
  • Claims covering specific formulations, such as dosage forms, excipient combinations, or delivery systems.
  • Claims underlining a manufacturing process optimized for the claimed compound or formulation.

Critical considerations:

  • Narrow claims limit the scope but strengthen enforceability.
  • Broad claims, if granted, extend protection but risk rejection or invalidation if overly broad.

In BRPI0512177, claims focus on a particular chemical structure or class, with dependent claims refining the invention by indicating specific embodiments.

Patent Landscape Overview in Brazil and Global Context

Brazil Patent Landscape for Drugs

Brazil's patent landscape for pharmaceuticals is characterized by a mix of:

  • Patent filings focused on chemical compounds, formulations, or manufacturing processes.
  • An emphasis on patentability based on inventive step and industrial application, with strict scrutiny under the Brazilian Patent Office (INPI).
  • Use of patent term adjustments and patent term extensions are generally not available for pharmaceuticals.

International Patent Filings

The applicant likely pursued patent protection through regional or international routes.

  • Patent Cooperation Treaty (PCT): Possible application to extend protection globally.
  • Regional filings: Such as in the INAPI (South America), EPO (Europe), or USPTO (United States).

Key Competitors and Patent Families

A search indicates several related patents targeting similar compounds for similar indications, often filed in Brazil and worldwide.

  • Similar chemical structures are patented in the US as part of larger patent families.
  • Competing claims often focus on different delivery systems or manufacturing methods.

Patent Validity Status

The patent's validity in Brazil depends on several factors:

  • Examination outcome: Granted versus opposed or challenged.
  • Prior art searches: Developed by the patent office or third parties.
  • Maintenance status: Annual fees paid and upheld through initial periods.

Licensing and Infringement Risks

  • Infringement on BRPI0512177 could occur if another entity markets a formulation or process within the scope of its claims.
  • Licensing opportunities are contingent on patent strength, licensing history, and patent owner strategies.
  • The patent lifespan is typically 20 years from filing, with possible extensions if applicable.

Summary of Technical and Legal Details

Feature Details
Patent Number BRPI0512177
Filing Date (Assumed circa 2005, based on publication number)
Grant Date (Specific date needed from official records)
Patent Term 20 years from filing, subject to maintenance
Patent Type Utility patent
Geographical Scope Brazil
Focus Chemical compounds, formulations, manufacturing process

Key Takeaways

  • The patent broadly protects a specific drug composition or process, with claims refined for particular embodiments.
  • Its landscape aligns with Brazil's strict patentability criteria for pharmaceuticals.
  • Global patent strategies likely include filings in other jurisdictions to maximize coverage.
  • The enforceability depends on ongoing maintenance, opposition, and validity challenges.
  • Competitive overlap exists, especially with patents on similar compounds or delivery methods.

FAQs

  1. What are the main limitations of patent BRPI0512177?
    Its claims are specific to certain compounds and formulations, making it potentially vulnerable if prior art exists that predates the filing date.

  2. Can this patent be extended beyond 20 years?
    No. Brazilian patent law generally limits patent term to 20 years from the filing date. Extensions are rare and typically not granted for pharmaceuticals.

  3. Is the patent enforceable in other markets?
    No. It only covers Brazil. To block or license in other countries, separate patents must be filed and granted.

  4. What common challenges could weaken the patent's enforceability?
    Challenges include prior art disclosures, lack of inventive step, or procedural issues like non-payment of maintenance fees.

  5. How does the patent landscape influence R&D investments?
    A strong patent position can protect investments. Overlapping patents or weak claims may discourage development or trigger licensing negotiations.


References

  1. INPI. (n.d.). Patent Search. Instituto Nacional da Propriedade Industrial. Retrieved from http://extranet.inpi.gov.br/pePI/
  2. World Intellectual Property Organization (WIPO). (2022). Patent Landscapes & Strategies. WIPO Publications.
  3. Brazilian Patent Law (Law No. 9279/1996). (1996). Brasil.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.